BIOMAT Database Logo BIOMAT Database Logo

Biochemical and mitogenic properties of the heparin-binding growth factor HARP. 1995

K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Laboratoire de Recherche sur la Croissance Cellulaire, Université Paris Val de Marne, Créteil, France.

Heparin affin regulatory peptide (HARP), also called Pleiotrophin (PTN), is a polypeptide that displays a high affinity for heparin and that shares approximately 50% sequence homology with Midkine (MK). According to this structural homology, these two molecules constitute a new family of heparin-binding proteins. The biological properties of HARP and MK remain largely a subject of debate. Both proteins have been described as neurite outgrowth promoting agents whereas until recently the mitogenic activity has been controversial. The aim of this review is to summarize the information on HARP with special focus on the recent data relating to its mitogenic properties.

UI MeSH Term Description Entries
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D011975 Receptors, Mitogen Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes. Lectin Receptors,Mitogen Receptors,Receptors, Lectin,Mitogen Receptor,Receptor, Mitogen
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Receptor binding and mitogenic properties of mouse fibroblast growth factor 3. Modulation of response by heparin.
October 1995, The Journal of biological chemistry,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes.
December 1993, Experimental cell research,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas.
October 1998, Acta neuropathologica,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Mitogenic effects of platelet-derived growth factor, fibroblast growth factor, transforming growth factor-beta, and heparin-binding serum factor for adult mouse Schwann cells.
December 1994, Journal of neuroscience research,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids.
January 2002, Journal of immunoassay & immunochemistry,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic rats.
October 1995, Arteriosclerosis, thrombosis, and vascular biology,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
July 1999, Molecular pharmacology,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
High concentration of glucose increases mitogenic responsiveness to heparin-binding epidermal growth factor-like growth factor in rat vascular smooth muscle cells.
October 1997, Arteriosclerosis, thrombosis, and vascular biology,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Heparin-binding EGF-like growth factor.
December 1997, Biochimica et biophysica acta,
K Laaroubi, and F Vacherot, and J Delbé, and D Caruelle, and D Barritault, and J Courty
Retinoic acid potentiates the neurotrophic but not the mitogenic action of the class 1 heparin-binding growth factor (HBGF-1).
February 1991, Brain research,
Copied contents to your clipboard!